Lisata Therapeutics (LSTA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

LSTA Lisata Therapeutics

Watchlist

2.880
+0.036+1.27%

Close Nov 22 16:00 ET

2.880
0.0000.00%

Post 20:01 ET

24.18MMarket Cap-1147P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Lisata Therapeutics Analyst Ratings
BenzingaNov 21 06:35 ET · Ratings
H.C. Wainwright Maintains Lisata Therapeutics(LSTA.US) With Buy Rating, Maintains Target Price $15
Moomoo NewsNov 21 06:31 ET · Ratings
Lisata Therapeutics Named 'Specialized BioTherapeutics Company of the Year' at 2024 BioTech Breakthrough Awards | NASDAQ:LSTA
Proactive InvestorsNov 19 09:36 ET
Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for 'Specialized BioTherapeutics Company of the Year'
Lisata TherapeuticsNov 19 00:00 ET
Lisata Therapeutics, Inc. (LSTA) Q3 2024 Earnings Call Transcript Summary
moomoo AINov 12 22:47 ET · Conference Call
Lisata Therapeutics Reports Promising Q3 2024 Results
TipRanksNov 12 16:47 ET

Comments

Jaguar8

Nov 19 07:31

NEWS

$Lisata Therapeutics (LSTA.US)$
Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ‘Specialized BioTherapeutics Company of the Year’

Teddy123

Nov 6 08:27

Lisata Therapeutics and Valo Therapeutics Announce Preclinical Research Collaboration

$Lisata Therapeutics (LSTA.US)$
BASKING RIDGE, N.J. and HELSINKI, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, and Valo Therapeutics Oy (“ValoTx”), a private company developing novel, adaptable immunotherapies for the treatment of cancer, are...

Jaguar8

Oct 28 07:31

NEWS

$Lisata Therapeutics (LSTA.US)$
Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of Endometriosis
Lisata Therapeutics (Nasdaq: LSTA) has entered into a sponsored research agreement with the University of Cincinnati to study certepetidecombined with bevacizumab for treating endometriosis. The research aims to leverage certepetide's selective targeting of endometrial tissue through surface integrin an...